r-metHuLeptin

Phase 1/2Completed

0 watching 0 views this week⚡ Active

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Fasting

Conditions

Fasting

Trial Timeline

Oct 1, 2002 → Dec 1, 2016

NCT ID

NCT00140231

About r-metHuLeptin

r-metHuLeptin is a phase 1/2 stage product being developed by Amgen for Fasting. The current trial status is completed. This product is registered under clinical trial identifier NCT00140231. Target conditions include Fasting.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (2)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00140231	Phase 1/2	Completed	Oct 1, 2002	Dec 1, 2016	Fasting
NCT00140205	Phase 1	Completed	Feb 1, 2001	Dec 1, 2016	Energy Deficiency Due to Short-term Fasting

Competing Products

20 competing products in Fasting

See all competitors

Product	Company	Stage	Hype Score
Lamotrigine Tablets 25 mg + Lamotrigine	Ipca Laboratories	Phase 1	33
Metformin Hydrochloride Extended-Release Tablets USP 750 mg + GLUCOPHAGE®XR	Ipca Laboratories	Phase 1	33
Ondansetron Tablets USP 8 mg + Ondansetron Hydrochloride	Ipca Laboratories	Phase 1	33
Metformin Hydrochloride Extended-Release Tablets USP 750 + GLUCOPHAGE®XR tablet 750 mg	Ipca Laboratories	Phase 1	33
Quetiapine Fumarate Tablets 25 mg + Quetiapine Fumarate	Ipca Laboratories	Phase 1	33
Metoprolol Succinate ER Tablets 50 mg + 'TOPROL-XL®' ER Tablets 50 mg	Ipca Laboratories	Phase 1	33
Etodolac Capsules USP 300 mg + Etodolac	Ipca Laboratories	Phase 1	33
Risperidone Tablet 1 mg + Risperidone	Ipca Laboratories	Phase 1	33
Lisinopril and Hydrochlorothiazide Tablets (20+25) mg + Zestoretic® 20/25 lisinopril/hydrochlorothiazide Tablets	Ipca Laboratories	Phase 1	33
Allopurinol + Allopurinol	Ipca Laboratories	Phase 1	33
Levocetirizine Dihydrochloride 5 mg Tablets	Ipca Laboratories	Phase 1	33
Etodolac Extended Release Tablets USP 600mg + Etodolac Extended Release Tablets 600mg	Ipca Laboratories	Phase 1	33
Carvedilol Tablets USP 12.5 mg + Carvedilol	Ipca Laboratories	Phase 1	33
Metoprolol Succinate ER Tablet 200 mg + 'TOPROL-XL®' ER Tablets 200 mg	Ipca Laboratories	Phase 1	33
Etodolac Tablets USP 500mg + Etodolac Tablets USP 500 mg	Ipca Laboratories	Phase 1	33
Etodolac Extended Release Tablets USP 600mg + Etodolac Extended Release Tablets 600mg	Ipca Laboratories	Phase 1	33
Bisoprolol Fumarate Tablet 10 mg + Bisoprolol	Ipca Laboratories	Phase 1	33
Lisinopril Tablets 40 mg + Lisinopril	Ipca Laboratories	Phase 1	33
r-metHuLeptin	Amgen	Phase 1	32
Olanzapine	Dr. Reddy's Laboratories	Phase 1	30

Other Products from Amgen